A neural stem-cell treatment for progressive multiple sclerosis

Affiliations

¹ The New York Stem Cell Foundation Research Institute, New York, NY, USA. vfossati@nyscf.org.
² Department of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK.

Comment

Valentina Fossati et al. Nat Med. 2023 Jan.

. 2023 Jan;29(1):27-28.

doi: 10.1038/s41591-022-02164-9.

¹ The New York Stem Cell Foundation Research Institute, New York, NY, USA. vfossati@nyscf.org.
² Department of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK.

No abstract available

Comment on

Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
Genchi A, Brambilla E, Sangalli F, Radaelli M, Bacigaluppi M, Furlan R, Andolfo A, Drago D, Magagnotti C, Scotti GM, Greco R, Vezzulli P, Ottoboni L, Bonopane M, Capilupo D, Ruffini F, Belotti D, Cabiati B, Cesana S, Matera G, Leocani L, Martinelli V, Moiola L, Vago L, Panina-Bordignon P, Falini A, Ciceri F, Uglietti A, Sormani MP, Comi G, Battaglia MA, Rocca MA, Storelli L, Pagani E, Gaipa G, Martino G. Genchi A, et al. Nat Med. 2023 Jan;29(1):75-85. doi: 10.1038/s41591-022-02097-3. Epub 2023 Jan 9. Nat Med. 2023. PMID: 36624312 Free PMC article. Clinical Trial.

1. Pluchino, S., Smith, J. A. & Peruzzotti-Jametti, L. Trends Mol. Med. 26, 898–912 (2020). - DOI
1. Genchi, E., Brambilla, E., Sangalli, F. & Martino, G. Nat. Med. https://doi.org/10.1038/s41591-022-02097-3 (2023).
1. Lindvall, O. et al. Lancet 332, 1483–1484 (1988). - DOI
1. Mazzini, L. et al. Stem Cells Transl. Med. 8, 887–897 (2019). - DOI
1. Baloh, R. H. et al. Nat. Med. 28, 1813–1822 (2022). - DOI